Recombinant
RabMAb

Recombinant Anti-5 Lipoxygenase/5-LO antibody [EP6072(2)] (ab169755)

Publishing research using ab169755? Please let us know so that we can cite the reference in this datasheet.

ab169755 has been referenced in 8 publications.

  • Li C  et al. Correlation of LOX-5 and COX-2 expression with inflammatory pathology and clinical features of adenomyosis. Mol Med Rep 19:727-733 (2019). PubMed: 30387822
  • Oguh-Olayinka L  et al. The Investigation of Lipoxygenases as Therapeutic Targets in Malignant Pleural Mesothelioma. Pathol Oncol Res N/A:N/A (2019). PubMed: 30941737
  • Khophai S  et al. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. Onco Targets Ther 11:7019-7029 (2018). PubMed: 30410359
  • Rodríguez-Blanco G  et al. Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer. Oncotarget 9:36444-36456 (2018). PubMed: 30559929
  • Zuo G  et al. Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats. Mol Brain 11:9 (2018). PubMed: 29439730
  • Menkhorst EM  et al. Invasive trophoblast promote stromal fibroblast decidualization via Profilin 1 and ALOX5. Sci Rep 7:8690 (2017). PubMed: 28821715
  • Li C  et al. Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism. Sci Rep 6:36949 (2016). WB . PubMed: 27833128
  • Che XH  et al. Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro. Oncol Rep 35:1680-8 (2016). PubMed: 26707712

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up